MSB 3.21% $1.13 mesoblast limited

banter and General Discussion, page-4776

  1. 3,953 Posts.
    lightbulb Created with Sketch. 1352
    I 100% agree with Left-e.
    Ask yourself this.
    How can MSB submit the BLA without parameters been set for the final potency assay. This would require OTAC input and agreement with MSB. Correct?
    So given news of the BLA been submitted we can assume that the OTAC team have sighed off on the finale potency assay. The review of the BLA even though not submitted is in my opinion well under way.

    Good luck
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.